Opening book details…
About this Medicine article
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials by Leonardi, Craig; Reich, Kristian; Foley, Peter; Torii, Hideshi; Gerdes, Sascha; Guenther, Lyn; Gooderham, Melinda; Ferris, Laura K.; Griffiths, Christopher E. M.; ElMaraghy, Hany; Crane, Heidi; Patel, Himanshu; Burge, Russel; Gallo, Gaia; Shrom, David; Leung, Ann; Lin, Chen-Yen; Papp, Kim is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Leonardi, Craig; Reich, Kristian; Foley, Peter; Torii, Hideshi; Gerdes, Sascha; Guenther, Lyn; Gooderham, Melinda; Ferris, Laura K.; Griffiths, Christopher E. M.; ElMaraghy, Hany; Crane, Heidi; Patel, Himanshu; Burge, Russel; Gallo, Gaia; Shrom, David; Leung, Ann; Lin, Chen-Yen; Papp, Kim
- Publisher
- Springer Healthcare Communications; Springer-Verlag; Springer Verlag; [Heidelberg]: Springer Healthcare; Springer Science and Business Media LLC (ISSN 2193-8210)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)